Insiders Trades
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Feb 2026 for Organogenesis Holdings Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Prathyusha Duraibabu: trading record in brief
This profile gathers the share dealings of Prathyusha Duraibabu across 2 companies, led by Sangamo Therapeutics, Inc and Organogenesis Holdings Inc. In total, 33 filings cover trades dated from 11 June 2021 to 18 February 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 20 February 2026, the filings show a share grant in Organogenesis Holdings Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Prathyusha Duraibabu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations33 total
48,828 shares0Class A Common StockSEC:0002064832-26-000051:0
36,676 shares@ US$0.39854.7% of flowCommon StockSEC:0001779092-26-000002:0
2,544 shares@ US$0.41660.4% of flowCommon StockSEC:0001779092-25-000007:0
45,225 shares@ US$0.6610.2% of flowCommon StockSEC:0001779092-25-000005:0
1,792 shares@ US$0.58630.4% of flowCommon StockSEC:0001415889-25-023074:0
31,866 shares@ US$0.47985.8% of flowCommon StockSEC:0001415889-25-020246:0
1,792 shares@ US$0.47330.3% of flowCommon StockSEC:0001415889-25-014693:0
31,866 shares@ US$0.776310.3% of flowCommon StockSEC:0001415889-25-011285:0
1,792 shares@ US$1.000.8% of flowCommon StockSEC:0001415889-25-005705:0
49,575 shares0Class A Common StockSEC:0001062993-25-003207:0
129,242 shares@ US$1.1567.4% of flowCommon StockSEC:0001415889-25-002019:0
1,787 shares@ US$1.881.5% of flowCommon StockSEC:0001415889-24-027703:0
1,787 shares@ US$0.860.7% of flowCommon StockSEC:0001415889-24-022308:0
892 shares@ US$0.60770.2% of flowCommon StockSEC:0001415889-24-016686:0
1,787 shares@ US$0.600.5% of flowCommon StockSEC:0001415889-24-014779:0
5,474 shares@ US$1.132.7% of flowCommon StockSEC:0001415889-24-005548:0
51,020 shares0Class A Common StockSEC:0001062993-24-004304:0
712,500 shares0Common StockSEC:0001415889-24-001756:0
1,329 shares@ US$0.38210.2% of flowCommon StockSEC:0001209191-23-056778:0
1,329 shares@ US$0.770.4% of flowCommon StockSEC:0001209191-23-047585:0
864 shares@ US$1.190.5% of flowCommon StockSEC:0001209191-23-036788:0
1,328 shares@ US$1.330.8% of flowCommon StockSEC:0001209191-23-032906:0
345 shares@ US$1.660.2% of flowCommon StockSEC:0001209191-23-021427:0
53,438 shares0Common StockSEC:0001209191-23-016390:0
65,737 shares0Class A Common StockSEC:0001062993-23-004886:0
25 of 33 declarations
